HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

Health Catalyst, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$1.71−0.02 (-0.87%)

Close on Oct 19, 2026

Market cap: $126.47M
P/E (TTM): –
Dividend yield: –

Health Catalyst, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Revenue	311	307	296	276	242	189	155	113	73
Cost of Revenue	159	166	164	143	124	98	75	60	44
Gross Profit	152	141	132	133	118	91	80	53	29
Research & Development	50	58	73	76	63	54	46	39	28
Selling, General & Admin	102	111	144	149	161	115	79	67	41
Selling & Marketing	52	54	67	88	75	55	47	44	26
General & Administrative	50	57	77	62	86	59	32	23	15
Advertising Expenses	3.10	5.10	2.60	5.70	4.40	4.30	4.90	5.00	5.90
Operating Expenses	313	211	259	273	261	187	134	113	75
Operating Income	-161	-70	-127	-140	-144	-96	-55	-60	-46
Merger & Restructuring Charges	–	–	–	–	0	0	–	–	–
Asset Impairment Charges	110	0	0	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0.04	0.03	0.05
Pretax Income	-177	-69	-118	–	–	–	–	–	–
Income Tax Expense	0.72	0.33	0.36	-4.28	-6.90	-1.19	0.14	-0.14	0.03
Net Income	-178	-70	-118	-137	-153	-115	-60	-62	-47
Net Income to Common	-178	-70	-118	-137	-153	-115	-241	-114	-59
EPS (Basic)(per share)	-2.55	-1.15	-2.09	-2.56	-3.23	-2.91	-12.86	-23.76	-12.13
EPS (Diluted)(per share)	-2.55	-1.15	-2.09	-2.63	-3.23	-2.91	-12.86	-23.76	-12.13
Shares Outstanding (Basic, Weighted)(shares)	70	60	56	54	47	40	19	4.80	4.85
Shares Outstanding (Diluted, Weighted)(shares)	70	60	56	54	47	40	19	4.80	4.85
EBITDA	-110	-28	-85	-92	-106	-77	-46	-53	-40
Provision for Credit Losses	1.50	1.20	1.82	0.69	0.50	0.86	0	0.36	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 51.3%
Operating margin: -84.4%
Net margin: -90.6%
Return on equity, FY2025: -58.3%

Financial strength

Current ratio: 2.70
Debt to equity: 1.52
Debt to assets: 42.8%
Cash to current liabilities: 65.9%

Valuation

P/E ratio: –
Price to sales: 0.43
Price to book: 1.25
Dividend yield: –